# RYDAPT

NDC: 0078-0698
Generic name: RYDAPT
Labeler / Manufacturer: Novartis Pharmaceuticals Corporation
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: CAPSULE, LIQUID FILLED
Routes: ORAL
Marketing started: 20170428

FDA application: NDA207997

## Active ingredients

- MIDOSTAURIN: 25 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0078-0698"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0078-0698
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=11fa3fc9-6776-49a6-b1c1-653f627c3e58